| Literature DB >> 22027552 |
Deepak B Thimiri Govinda Raj1, Bart Ghesquière, Arun Kumar Tharkeshwar, Katrijn Coen, Rita Derua, Dieter Vanderschaeghe, Evelien Rysman, Murali Bagadi, Pieter Baatsen, Bart De Strooper, Etienne Waelkens, Gustaaf Borghs, Nico Callewaert, Johan Swinnen, Kris Gevaert, Wim Annaert.
Abstract
We manufactured a novel type of lipid-coated superparamagnetic nanoparticles that allow for a rapid isolation of plasma membranes (PMs), enabling high-resolution proteomic, glycomic and lipidomic analyses of the cell surface. We used this technology to characterize the effects of presenilin knockout on the PM composition of mouse embryonic fibroblasts. We found that many proteins are selectively downregulated at the cell surface of presenilin knockout cells concomitant with lowered surface levels of cholesterol and certain sphingomyelin species, indicating defects in specific endosomal transport routes to and/or from the cell surface. Snapshots of N-glycoproteomics and cell surface glycan profiling further underscored the power and versatility of this novel methodology. Since PM proteins provide many pathologically relevant biomarkers representing two-thirds of the currently used drug targets, this novel technology has great potential for biomedical and pharmaceutical applications.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22027552 PMCID: PMC3261717 DOI: 10.1038/msb.2011.74
Source DB: PubMed Journal: Mol Syst Biol ISSN: 1744-4292 Impact factor: 11.429
Figure 1Schematic diagram and quality control of the PM isolation procedure using SPMNPs. (A) Stepwise outline of the SPMNP-based affinity purification of PMs: (1) SPMNPs are incubated with cell monolayers at 4 °C for 15 min; (2) after washing, cells are harvested, homogenized and centrifuged (200g, 10 min) to yield a PNS, (3) PMs are magnetically retained on an LS column, (4) followed by elution and concentration by ultracentrifugation and finally (5) protein/lipid are extracted for subsequent analysis. (Inset) Coommassie Brilliant Blue staining of PNS, unbound (UB) and bound (B) fractions obtained from WT MEFs (first lane: SeeBlue plus2 rainbow protein marker (Invitrogen)). The distinct protein profile in the bound fraction underscores the high enrichment for PMs. (B) Confocal laser scanning microscopy images of WT MEFs incubated with fluorescently modified NH2-lipid end-group SPMNPs and Alexafluor-647 conjugated cholera toxin subunit B (CTB) (15 min at 4 °C). (C) TEM of WT, PSENdKO and hPSEN1rescue MEFs showing SPMNPs adhering to the cell surface (arrowheads). (D) TEM of an isolated PM fraction of WT, PSENdKO and hPSEN1rescue MEFs showing uniform long PM sheets decorated with SPMNPs, that were virtually devoid of other subcellular organelles. (E) (Left) Representative western blot analysis showing the strong enrichment for the PM marker Na+K+-ATPase between total cell extracts (TOTAL) and isolated PMs (BOUND) for all three investigated cell lines. (Right) Western blot analysis demonstrating endogenous PSEN1 in WT and exogenous human PSEN1 in PSENdKO-rescued MEFs. (F) Quantitative western blot analysis of the indicated organelle marker proteins (x axis) in isolated PM fractions as a percentage of the total cell lysate (y axis, presented in logarithmic scale) for WT, PSENdKO and hPSEN1rescue MEFs (mean±s.e.m., n=3). Na+K+-ATPase and FAS/CD95 were used as PM-localized integral membrane proteins. Overall, very-to-extreme low levels of contaminations were detected for all subcellular compartments as judged from the many marker proteins. RBI represents ER while the membrane proteins p58 and RER1p reside in intermediate to cis-Golgi compartments. GM130 is a Golgi-associated protein while lamin, HSP60 and the membrane-associated PEX14p denote nuclear envelope, mitochondria and peroxisomes respectively. Rab7 represents late endosomes. Cytosolic and cytoskeletal marker proteins are GAPDH and actin/tubulin. Proteins were resolved in a precast 4–12% SDS–PAGE gel. (*) Represents integral membrane proteins and (°) represents membrane-associated/-anchored proteins. Line denotes 1% contamination level on the logarithmic y axis.
Figure 2Qualitative MS/MS-based PM proteomics. (A) Pie chart showing that almost 70% of the proteins identified in the isolated PM fraction of WT MEFs (of a total of ∼1000 identified in one magnetic isolation procedure) are expected to be PM proteins, based on Gene Ontology annotations. About 14% are annotated to the ER, 7% to Golgi and 4% nuclear. (B) Subclassification of PM proteins with 61% being integral membrane proteins and 24% associated. (C, D) Comparative classification of PM proteomes of WT (inner circle) and PSENdKO (outer circle) MEFs does not show gross alterations in the biological processes and molecular function profiles, respectively.
Figure 3Quantitative proteomics using shotgun approach on WT, PSENdKO and PSEN1rescue MEFs. Scatter plot of the PM protein in Log2 ratio's of PSENdKO versus WT (y axis) and WT versus PSEN1rescue (x axis) generated using Tableau software. For the x axis, only ratio's in the interval (−1, 1) between WT versus PSEN1rescue are taken (hence not significantly regulated between WT and PSEN1rescue PM). Analysis of the Log2 ratio's of these proteins in PSENdKO versus WT (y axis) identified 41 proteins that were significantly higher expressed in WT PMs (or downregulated in PSENdKO PMs) (ratio>2, marked blue circles with accession number as opposed to unregulated proteins (unmarked blue circles)). Identified proteins are listed in Table I along with their known or proposed functions.
List of 41 differentially regulated proteins between WT/PSENdKO and WT/PSEN1rescue along with their known or proposed functions
| Annotation | Description | WT/rescue ratio | WT/dKO ratio | Function/location | |
|---|---|---|---|---|---|
| Proteins are grouped according to their functions in cell adhesion/migration ( | |||||
| Q64314 | CD34 (hematopoietic progenitor cell antigen CD34) | 1.23 | 3.38 | Cell adhesion | |
| P15379 | CD44 | 1.72 | 5.91 | Cell adhesion/integrin signaling/raft associated | |
| Q61735 | CD47 | 1.48 | 5.2 | Cell adhesion/integrin signaling/raft associated | |
| Q62470 | ITA3 (integrin α-3) | 0.84 | 3.25 | Cell adhesion | |
| P09055 | Integrin β | 1.96 | 6.59 | Cell adhesion/negative regulation of cell migration | |
| Q91ZU6 | BPA1 (bullous pemphigoid antigen 1) | 0.99 | 3.23 | Cell adhesion/calcium ion binding | |
| P13595 | NCAM1 (neural cell adhesion molecule 1) | 1.32 | 4.28 | Cell adhesion/GPI | |
| Q80TH2 | LAP2 | 1.31 | 3.06 | Cell junction | |
| Q7TT50 | MRCKB (serine/threonine-protein kinase MRCK β) | 1.48 | 3.31 | Cell junction | |
| P49817 | Caveolin-1 | 1.34 | 3.88 | Caveolae associated | |
| Q03145 | EPHA2 (ephrin type-A receptor 2) | 0.71 | 3.23 | Caveolae associated | |
| Q62165 | Dystroglycan | 0.75 | 5.38 | Caveolae associated/calcium release | |
| Q69ZN7 | Myoferlin | 1.81 | 7.07 | Caveolae/lipid raft associated | |
| Q91ZX7 | LRP1 | 1.41 | 2.44 | Endocytosis/cholesterol homeostasis | |
| Q60767 | Lymphocyte antigen 75 | 1.02 | 3.77 | Endocytosis | |
| Q99JB8 | PACN3 (protein kinase C and casein kinase II protein 3) | 1.49 | 3.9 | Endocytosis | |
| P63024 | VAMP3 | 0.92 | 2.29 | Endosomal SNARE/required for integrin transport | |
| Q9QY76 | VAPB (vesicle-associated membrane protein-B) | 0.68 | 15.09 | Ligand for Eph receptor | |
| O09044 | SNP23 (synaptosomal-associated protein 23) | 1.7 | 2.86 | Plasma membrane SNARE/involved in migration | |
| Q9CQW1 | YKT6 (synaptobrevin) | 1.3 | 2.92 | Plasma membrane SNARE | |
| Q3TZZ7 | ESYT2 (extended synaptotagmin-2) | 0.69 | 3.45 | Exocytosis | |
| P17047 | LAMP-2 | 1.11 | 2.65 | Late endosome associated | |
| Q9DC51 | GNAI3 (guanine nucleotide-binding protein subunit-α) | 0.97 | 2.07 | GTPase/vesicular trafficking | |
| P35278 | RAB5 | 0.96 | 2.76 | Early endosome fusion | |
| P61027 | RAB10 | 0.99 | 2.66 | Endosome recycling to PM | |
| P46638 | Rab11B | 1.25 | 3.5 | Endosome recycling to PM | |
| Q9DD03 | RAB13 (Ras-related protein Rab13) | 1.14 | 4.52 | Endosomal sorting | |
| P35293 | RAB18 (Ras-related protein Rab18) | 1.47 | 4.69 | Endosomal sorting | |
| Q6PHN9 | RAB35 (Ras-related protein Rab35) | 0.88 | 2.91 | Endosome recycling to PM | |
| P63321 | RALA (Ras-related protein Ral-A) | 1.47 | 4.19 | GTPase/vesicular trafficking | |
| Q8BU31 | RAP2C (Ras-related protein Rap-2c) | 1.14 | 4.95 | GTPase/vesicular trafficking | |
| Q9JIW9 | Ras-related protein Ral-B/RABIB | 0.81 | 3.65 | GTPase/vesicular trafficking | |
| P62835 | Ras-related protein Rap-1A/RAB1A | 1.05 | 3.65 | GTPase/vesicular trafficking | |
| Q80U72 | SCRIB (protein scribble homolog OS) | 0.93 | 2.6 | GTPase/cell polarity and migration | |
| Q9QXX0 | JAG1 (protein jagged-1) | 1.74 | 4.51 | Notch signaling | |
| Q62312 | TGFR2 | 1.5 | 5.52 | TGF signaling | |
| P57716 | Nicastrin | 1.51 | 21.23 | Component of γ-secretase complex | |
| Q8VDN2 | AT1A1 (sodium/potassium-transporting ATPase α-1) | 1.47 | 3.16 | Sodium/potassium ion transport | |
| P55012 | S12A2 (solute carrier family 12 member 2) | 1.64 | 6.07 | Sodium/potassium ion transport | |
| Q61165 | SL9A1 (sodium/hydrogen exchanger 1) | 1.51 | 4.08 | Sodium/potassium ion transport | |
Figure 4Validation of quantitative proteomics data using western blot analysis and indirect immunofluorescence microscopy. (A, B) Western blot analysis of PNS and PM fractions for various proteins that were significantly downregulated in PSENdKO MEFs compared with WT/PSEN1rescue MEFs as obtained by quantitative proteome analysis following shotgun approach. (A) Proteins (12 μg protein/lane) were resolved on 4–12% precast SDS–PAGE gels, transferred to nitrocellulose and immunoprobed for the indicated proteins isolated from PM using the SPMNPs-based isolation method. NCT and LAMP-2 were immunoprobed after PM protein isolation using cell surface biotinylation. (B) Quantification of the ratio of the indicated proteins in PSENdKO PM fractions normalized to WT. No mature NCT was detected at the surface of PSENdKO MEFs (mean ratio±s.e.m., n=3, *P<0.05). (C–E) Altered cell morphology and localization of adhesion and migration proteins in PSENdKO MEFs. WT, PSENdKO and hPSEN1rescue MEFs were fixed and immunostained for caveolin-1 and myoferlin (C); CD47 and caveolin-1 (D); and F-actin (using phalloidin conjugated to Alexafluor-488) and vinculin (E). (F) Filipin staining reveals the intracellular accumulation of cholesterol in PSENdKO MEFs in contrast to a prominent cell surface localization in WT and hPSEN1rescue MEFs. Scale bar=10 μm in all panels.
Figure 5FACE-based glycan profiling and N-glycoproteomics. (A) Subcellular localization classification of glycoproteins identified from SPMNPs-based PM isolation. For known and characterized proteins, protein subcellular localization was classified based from the SWISS-PROT database. For N-glycosylation, sites from hypothetical proteins and peptide sequences were identified using gene ontology. (B) N-glycan profile (before and after sialidase treatment) of PM fractions derived from WT and PSENdKO MEFs. Sialylated N-glycans are represented in red and gray peaks originate from the presence of Nonidet P-40 detergent. [: galactose, : N-acetylglucosamine, : mannose, : fucose; symbols are those suggested by the Consortium for Functional Glycomics (http://glycomics.scripps.edu/CFGnomenclature.pdf)].
Figure 6Quantitative lipidomics. (A) Enrichment plot of PM versus total cell extracts of WT and PSENdKO MEFs for cholesterol (Chol) and the following major lipid families: PI, PE, PC, PS and SM. (B) Lipid ratio levels in total cell extracts and in PM fractions of PSENdKO versus WT MEFs, respectively. Increases are essentially observed in total cell extracts of PSENdKO, but not in their PM fraction. Cholesterol levels were determined by the amplex cholesterol assay. Total SM, SM species, PC and PI were determined by ESI-MS (mean±s.e.m., n=3; *P<0.05; **P<0.01; ***P<0.001; NS, not significant with respect to fold increase for (A) and with respect to WT for (B).